Review of uses of UPA beyond EC

ByCristina Puig

March 2025. A new article describes uses of ulipristal acetate (UPA) beyond emergency contraception: Uses of ulipristal acetate beyond emergency contraception: a narrative review (Ebersole, Ashley M. et al. Contraception). The review describes the extensive potential for UPA to treat and/or prevent conditions such as fibroids, breast cancer, and abnormal uterine bleeding, in addition to other known uses.  The American Society for Emergency Contraception (ASEC) and the European Consortium for Emergency Contraception (ECEC) commissioned this review, and developed this fact sheet based on its findings.

This work is part of a partnership with PSI, supported by the Children’s Investment Fund Foundation (CIFF).
 

Similar Posts

OTC status for EC recommended in Germany

ByCristina Puig

Following a long debate in Germany over whether LNG EC should have an over the counter status, the German Federal Institute for Drugs and Medical Devices recommended recently that emergency contraception pills should be available without a prescription. It is now up to the Minister of Health to decide whether he will adopt the recommendation…

Unaware of EC’s mechanism of action, Spanish Constitutional Court protects a pharmacist’s right to refuse to sell EC

ByCristina Puig

In 2008, a pharmacy in Seville, (in the southern Spain’s Andalusia region) was fined for refusing to sell emergency contraceptive pills (EC). The pharmacy challenged this, however, and the case was brought up to the Constitutional Court. In July 2015 this Court found that the pharmacist’s right to “ideological freedom” was violated by the sanction,…

Portugal: new EC practical guide for pharmacists

ByCristina Puig

In February 2015, the Portuguese Society of Contraception launched a practical EC guide for pharmacists. After Portugal decided to follow the European Union Commission recommendation to make UPA EC accessible directly from pharmacies without prescription, UPA EC is expected to be available directly from pharmacists in the country in the next few months. The Portuguese…

Europe: Sexual and reproductive health and rights policy Hub

Europe: Sexual and reproductive health and rights policy Hub

ByCristina Puig

November 2023 – The European Parliamentarian Forum for Sexual and Reproductive Health (EPF) launched the SRHR Policy Hub, an interactive platform through which country by country data from the Global Contraception Policy Atlas can be visualized, compared and downloaded. The Global Contraception Policy Atlas includes information on emergency contraception (EC) registration status, provision of EC…

Andorra: EC pills to be sold without prescription 

ByCristina Puig

June 6, 2018. The Ministry of Health of Andorra announced today that, upon review of the current provision policies for emergency contraceptive pills (ECPs), pharmacists have been informed that prescription requirements have been lifted. Andorra currently has both LNG and UPA ECP products in the market. The safety profile of ECPs, the critical importance of facilitating…

UPA medicine for uterine fibroids remains available in a number of Latin American and CIS countries

ByCristina Puig

December 2024.  The marketing authorisation for Esmya was withdrawn in July from the European Economic Area and Belarus, Moldova, Serbia, Ukraine and the United Kingdom, at the request of the marketing-authorisation holder. (See announcement on the European’s Medicines Agency’s website here). The withdrawal was due to commercial reasons and there is no change in the safety…